£

Professor Karadimitris has identified molecules that work together to cause myeloma cancer cells to grow in numbers and survive. He wants to understand more about how they do this so he can design and develop a new treatment for people with myeloma.

A male scientist - Professor Karadimitris - poses for a photograph in his lab

Professor Karadimitris in the lab

Project information

Lead researcher

Professor Anastasios Karadimitris, Imperial College London

Research team
  • A team at Imperial College London
Related conditions
  • Myeloma
Research type
  • Non-clinical
Region
  • London
Grant awarded
  • Project Grant
Status
Ongoing
Funding award date
September 2023
Amount awarded

£279,762.72

Project completion date
September 2023

The challenge

Myeloma is the second most common blood cancer that affects white blood cells called plasma cells. Plasma cells are made inside our bone marrow (the spongy material inside some of our bones) and are needed to make antibodies.

Antibodies are molecules that circulate in our blood, that find and kill bacteria and viruses that cause infections. Although new treatments have improved the survival of myeloma, the disease still has no cure.

The project

Professor Karadimitris and his team have identified molecules that are thought to allow myeloma cancer cells to grow in numbers and survive.

They plan to conduct some experiments in the lab to understand more about how these molecules work together to do this. They are going to look at the structure of these molecules to look at how they fit together and interact with other molecules in the cell with the aim of finding ways to disrupt this process.

The future

At the end of the project, the team hope to have a better understanding of how molecules inside cancer cells interact to cause myeloma cells to grow in numbers and survive.

They hope that this research will give them the knowledge to design and develop a new and better treatment for people with myeloma, getting us a step closer to a day where no lives are lost to this disease.

Help us beat blood cancer by funding a research project

  • £15 could help eight people newly diagnosed with blood cancer understand their condition.
  • £30 could help researchers study blood cancer cells to develop new treatments and improve early diagnosis.
  • £50 could help scientists identify genetic patterns in tumour samples to better understand how genes contribute to the development of blood cancer.
Donate